The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Tesco Leads Gains After Barclays Update

Fri, 08th Jan 2016 08:30

LONDON (Alliance News) - UK shares opened higher Friday, helped by stabilised trading in China, with miners recovering some ground after two days of losses and supermarket Tesco the biggest gainer at the open, benefiting from an upgrade by Barclays.

The FTSE 100 index was up 0.5% at 5,986.57 points, the FTSE 250 was up 0.4% at 16,858.39, and the AIM All-Share was flat at 726.27. In Europe, the CAC 40 in Paris was down 0.1%, while the DAX 30 in Frankfurt was up 0.2%.

Tesco was the best blue-chip performer shortly after the open, up 3.5%, after Barclays upgraded the supermarket to Overweight from Equal Weight.

Broker ratings drove the movements in the blue-chip index in early trade, with outsourcer Capita up 1.7% after Nomura initiated it with a Buy recommendation and Marks & Spencer Group up 0.3% thanks to upgrades from S&P Capital IQ and Berenberg.

Intu Properties was at the bottom of the FTSE 100, down 2.1%, after Exane BNP cut the shopping centre developer and owner to Underperform from Neutral. Societe Generale also downgraded the group to Sell from Hold.

Miners were taking back some of the losses seen in the last two sessions. Glencore was up 2.3%, Rio Tinto up 1.4%, and Anglo American up 0.9%.

In the FTSE 250, Vectura Group was up 4.5% after the British-based pharmaceutical firm said it has completed a clinical trial for VR315 in the US, its generic therapy for asthma, and provided an update on one of its other developments.

VR315 is inhaled by patients using Vectura's proprietary dry powder inhaler and formulation technology, and the company said it can now confirm its partner for the VR315 and also the VR506 programmes in the US is Roxane Laboratories, a subsidiary of Boehringer Ingelheim.

In AIM, investment company Prospex Oil & Gas was up 23% after it said it agreed its first conditional acquisition since converting into an AIM investing company in April last year with a deal to buy a 49% stake in Hutton Poland.

Prospex will pay a total of GBP620,000 in cash for the 49% stake, with GBP130,000 to be paid initially and the balance to be deferred up to the end of August. Hutton has stakes in a number of exploration licences in Poland, including the Kolo licence area in the Polish Central Lowlands.

Confidence among investors was somewhat restored after China's central bank raised slightly the yuan reference rate and the country's securities regulator suspended its recently implemented circuit-breaker mechanism used to prevent further losses in its stock market.

In a statement late Thursday, the China Securities Regulatory Commission said the circuit breaker system would be halted starting Friday because it had produced "more negative impact than positive effects". The commission did not say how long the suspension would remain in place. It said it will undertake research and solicit opinions to improve the system.

The People's Bank of China raised Friday its guidance rate for the yuan for the first time in nine trading days, Reuters reported.

The PBOC set its daily midpoint rate for the yuan at 6.5636 per dollar prior to the market open, Reuters said. Under China's currency regime the yuan is allowed to deviate 2% either side of the midpoint. The rate was set at 6.5646 to the dollar on Thursday, compared to 6.5314 on Wednesday.

The Shanghai Composite ended up 2.3% on Friday, the Hang Seng index in Hong Kong closed up 0.6%, but the Japanese Nikkei 225 index finished down 0.4%.

Germany's exports and imports recovered in November from October, according to data from Destatis. Exports rose 0.4% in November from October, when it fell 1.3%. Likewise, imports grew 1.6% reversing a 3.2% drop in October. Economists had forecast exports to grow 0.5% and imports to improve 1.0%.

Another report from Destatis showed German industrial production decreased unexpectedly in November. Industrial production fell a seasonally 0.3% month-over-month in November, confounding economists' expectations for a 0.5% rise. In October, production grew 0.2%.

Still ahead in the economic calendar, UK's goods trade balance is due at 0930 GMT. In the US, nonfarm payrolls are due at 1330 GMT, and wholesale inventories are due at 1500 GMT.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
19 Mar 2021 09:46

BROKER RATINGS: Barclays and Goldman Sachs downgrade Hammerson

BROKER RATINGS: Barclays and Goldman Sachs downgrade Hammerson

Read more
18 Mar 2021 10:36

Vectura shares rise on swing to profit, GBP115 million special payout

Vectura shares rise on swing to profit, GBP115 million special payout

Read more
18 Mar 2021 07:43

Royalty income, litigation win see Vectura beat expectations

(Sharecast News) - Vectura reported a 6.9% improvement in its total revenue on Thursday, to £190.6m, driven by development services and a surge in income from royalties.

Read more
11 Mar 2021 16:13

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
5 Mar 2021 12:29

Vectura delays results because of KPMG staff shortage

(Sharecast News) - Vectura delayed the publication of its annual results after KPMG asked for more time to audit the accounts because of a staff shortage caused by Covid-19.

Read more
2 Mar 2021 16:01

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
22 Jan 2021 09:32

LONDON BROKER RATINGS SUMMARY: Deutsche Bank Ups British Land, Landsec

LONDON BROKER RATINGS SUMMARY: Deutsche Bank Ups British Land, Landsec

Read more
12 Jan 2021 10:13

Vectura Forecasts 2020 Earnings To Top Board Expectations

Vectura Forecasts 2020 Earnings To Top Board Expectations

Read more
12 Jan 2021 08:16

Vectura reports 'strong' operational performance in 2020

(Sharecast News) - Inhaled medicines-focussed pharmaceutical company Vectura Group updated the market on its trading on Tuesday, saying it expected revenue and adjusted EBITDA for 2020 to be ahead of board expectations, following the fourth quarter approval of VR315 (US), or generic 'Advair', alongside Hikma.

Read more
30 Dec 2020 19:10

UK EXECUTIVE CHANGE SUMMARY: Nutrition Firm Director Joins Tate & Lyle

UK EXECUTIVE CHANGE SUMMARY: Nutrition Firm Director Joins Tate & Lyle

Read more
29 Dec 2020 12:04

Vectura Says Glaxo Will Not Appeal Award In Ellipta Litigation

Vectura Says Glaxo Will Not Appeal Award In Ellipta Litigation

Read more
29 Dec 2020 10:04

Glaxo not seeking re-hearing in Ellipta litigation, says Vectura

(Sharecast News) - Vectura said on Tuesday that GlaxoSmithKline has not sought to petition the US Court of Appeals for a re-hearing in the companies' ongoing litigation over GSK's Ellipta inhalers.

Read more
18 Dec 2020 17:08

LONDON MARKET CLOSE: Stocks Fall As Investors Sweat On Brexit Deal

LONDON MARKET CLOSE: Stocks Fall As Investors Sweat On Brexit Deal

Read more
18 Dec 2020 12:08

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

Read more
18 Dec 2020 10:45

UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura

UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.